FilingReader Intelligence

MicroPort CardioFlow to acquire remaining stake in MP CardioAdvent

June 4, 2025 at 05:06 PM UTC•By FilingReader AI

MicroPort CardioFlow Medtech Corporation (HKEX:2160) has announced a proposed acquisition of the remaining 49% equity interest in Shanghai MicroPort CardioAdvent Co., Ltd. for a total consideration of RMB170.86M. The acquisition, subject to Independent Shareholder approval at the Annual General Meeting scheduled for June 27, 2025, would result in MP CardioAdvent becoming a wholly-owned subsidiary. The consideration will be paid in installments to MicroPort Sinica and Shanghai Zuoqing.

This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com

Primary Source Document

(1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) DISCLOSEABLE AND CONNECTED TRANSACTION IN RELATION TO THE ACQUISITION OF THE REMAINING 49.00% EQUITY INTEREST IN MP CARDIOADVENT; AND (5) NOTICE OF ANNUAL GENERAL MEETINGJune 4, 2025 at 08:37 AM UTC

MicroPort CardioFlow Medtech Corporation

HKEX:2160•Hong Kong Exchange

RSS feed for MicroPort CardioFlow Medtech Corporation

News Alerts

Get instant email alerts when MicroPort CardioFlow Medtech Corporation publishes news

Free account required • Unsubscribe anytime

Browse RSS Feeds

Filing Activity Timeline

View Complete Filing History →